Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.090
-0.040 (-3.54%)
Jun 5, 2025, 4:00 PM - Market closed
Caribou Biosciences Employees
Caribou Biosciences had 147 employees as of December 31, 2024. The number of employees decreased by 11 or -6.96% compared to the previous year.
Employees
147
Change (1Y)
-11
Growth (1Y)
-6.96%
Revenue / Employee
$67,469
Profits / Employee
-$1,005,864
Market Cap
101.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CRBU News
- 8 days ago - Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference - GlobeNewsWire
- 6 weeks ago - Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 2 months ago - Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire